View Cart (0 items)

Items Tagged with 'teva pharmaceuticals'


Teva recalls 39,000 bottles of drug products due to manufacturing standards violations

May 27, 2014
The recalled production includes 2,532 bottles of anti-diabetes drug glyburide, which are being pulled off the U.S. market due to deviations from Current Good Manufacturing Practice.
Read More

Teva's application for patent extension on Copaxone rejected

April 8, 2014
The U.S. Patent and Trademark Office has rejected the request from Israeli pharma giant Teva Pharmaceuticals to have its patent protection on Copaxone extended until September 2015.
Read More